Under the Agreement, the JV will implement Orgenesis’ POCare cell therapy platform for clinical development and commercialization of cell and gene therapies within HYGEIA Group’s network of three ...
 |
| READ THE ORIGINAL POST AT markets.businessinsider.com |
